NasdaqGS - Nasdaq Real Time Price USD

iRhythm Technologies, Inc. (IRTC)

Time to buy IRTC?

140.46

+0.68

+(0.49%)

At close: May 14 at 4:00:01 PM EDT

140.46

0.00

(0.00%)

After hours: May 14 at 4:20:01 PM EDT

Time to buy IRTC?

Why iRhythm Technologies (IRTC) Is Among the Best Performing Healthcare Stocks to Buy Now

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where iRhythm Technologies, Inc. (NASDAQ:IRTC) stands against other best performing healthcare stocks to buy now. Trump’s Healthcare Executive Order Brings a Win On April 15, CNBC reported that President Trump’s […]

Insider Monkey 3 days ago

IRTC
+0.49%
Veracyte Stock Earns Relative Strength Rating Upgrade

Veracyte stock had its Relative Strength (RS) Rating upgraded from 70 to 76 Tuesday — a welcome improvement, but still short of the 80 or better score you prefer to see. Can You Really Time The Stock Market? IBD's unique RS Rating identifies technical performance by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.

Investor's Business Daily 8 days ago

VCYT

HIMS

IRTC
+0.49%
Progyny Stock Sees RS Rating Improve To 73

A Relative Strength Rating upgrade for Progyny shows improving technical performance. Will it continue?

Investor's Business Daily 9 days ago

HIMS

OPCH

PGNY
Masimo (MASI) Q1 Earnings Report Preview: What To Look For

Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings tomorrow after market close. Here’s what investors should know.

StockStory 9 days ago

MASI

IRTC
+0.49%
iRhythm Technologies First Quarter 2025 Earnings: Beats Expectations

iRhythm Technologies ( NASDAQ:IRTC ) First Quarter 2025 Results Key Financial Results Revenue: US$158.7m (up 20% from...

Simply Wall St. 11 days ago

IRTC
+0.49%
iRhythm Technologies Inc (IRTC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...

iRhythm Technologies Inc (IRTC) reports over 20% revenue growth, expands market presence, but faces reimbursement and legal challenges.

GuruFocus.com 12 days ago

IRTC
+0.49%
IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates

iRhythm Technologies (IRTC) delivered earnings and revenue surprises of -6.74% and 3.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 13 days ago

IRTC
+0.49%
iRhythm (NASDAQ:IRTC) Surprises With Strong Q1, Full-Year Sales Guidance is Optimistic

Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 20.3% year on year to $158.7 million. The company’s full-year revenue guidance of $695 million at the midpoint came in 2% above analysts’ estimates. Its non-GAAP loss of $0.95 per share was 1.5% below analysts’ consensus estimates.

StockStory 13 days ago

IRTC
+0.49%
iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

iRhythm Zio® Long-Term Continuous Monitoring (LTCM) system — commercially introduced in Japan as the Zio® ECG Recording and Analysis System — brings AI-powered, continuous, uninterrupted ECG monitoring for up to 14 days to JapanLaunch is timely amid a growing demand for early, accurate detection of arrhythmias in Japan, the second largest ambulatory cardiac monitoring market in the world, where the prevalence is expected to rise alongside an aging population1-3 SAN FRANCISCO, May 01, 2025 (GLOBE

GlobeNewswire 13 days ago

IRTC
+0.49%
iRhythm Technologies Announces First Quarter 2025 Financial Results

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2025. First Quarter 2025 Financial Highlights Revenue of $158.7 million, a 20.3% increase compared to first quarter 2024Gross margin of 68.8%, a 250-basis point increase compared to first quarter 2024Unrestricted cash, c

GlobeNewswire 13 days ago

IRTC
+0.49%
iRhythm Earnings: What To Look For From IRTC

Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be reporting results tomorrow afternoon. Here’s what investors should know.

StockStory 14 days ago

IRTC
+0.49%

RMD
iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

SAN FRANCISCO, April 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced the company will be participating in the upcoming Bank of America Securities 2025 Health Care Conference. iRhythm’s management is scheduled to present on Tuesday, May 13, 2025, 3:40 p.m. Pacific Time/6:40 p.m. Eastern Time. Interested parties may access a live and archived

GlobeNewswire 15 days ago

IRTC
+0.49%
iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups.Latest data showed Zio LTCM was associated with higher diagnostic yield and lower likelihood of repeat testing and cardiovascular events compared to all other LTCM products. SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) announced results from a large real-world retrospective

GlobeNewswire 16 days ago

IRTC
+0.49%
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

SAN FRANCISCO, April 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2025 after the close of trading on Thursday, May 1, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and

GlobeNewswire 27 days ago

IRTC
+0.49%
iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

Report highlights progress against key sustainability initiatives that reflect iRhythm’s commitment to delivering better data, better insights, and better health for allSAN FRANCISCO, April 16, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it has published its 2024 Corporate Sustainability Report, highlighting the company’s efforts to bu

GlobeNewswire 28 days ago

IRTC
+0.49%
3 Reasons IRTC is Risky and 1 Stock to Buy Instead

iRhythm has been on fire lately. In the past six months alone, the company’s stock price has rocketed 78.8%, reaching $102.62 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

StockStory last month

IRTC
+0.49%
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

Let’s dig into the relative performance of Masimo (NASDAQ:MASI) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

StockStory last month

MASI

IRTC
+0.49%

DXCM
1 Small-Cap Stock Worth Your Attention and 2 to Question

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

StockStory last month

IRTC
+0.49%

DBI
When Will iRhythm Technologies, Inc. (NASDAQ:IRTC) Turn A Profit?

With the business potentially at an important milestone, we thought we'd take a closer look at iRhythm Technologies...

Simply Wall St. last month

IRTC
+0.49%
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers.

StockStory last month

IRTC
+0.49%

DXCM

MASI

Performance Overview

Return	IRTC	S&P 500 (^GSPC)
YTD	+55.77%	+0.19%
1-Year	+41.29%	+12.31%
3-Year	+1.02%	+46.44%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

iRhythm Technologies, Inc. (IRTC)

Why iRhythm Technologies (IRTC) Is Among the Best Performing Healthcare Stocks to Buy Now

Veracyte Stock Earns Relative Strength Rating Upgrade

Progyny Stock Sees RS Rating Improve To 73

Masimo (MASI) Q1 Earnings Report Preview: What To Look For

iRhythm Technologies First Quarter 2025 Earnings: Beats Expectations

iRhythm Technologies Inc (IRTC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...

IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates

iRhythm (NASDAQ:IRTC) Surprises With Strong Q1, Full-Year Sales Guidance is Optimistic

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

iRhythm Technologies Announces First Quarter 2025 Financial Results

iRhythm Earnings: What To Look For From IRTC

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

3 Reasons IRTC is Risky and 1 Stock to Buy Instead

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

1 Small-Cap Stock Worth Your Attention and 2 to Question

When Will iRhythm Technologies, Inc. (NASDAQ:IRTC) Turn A Profit?

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Performance Overview